Location History:
- Munchen, DE (1998)
- M{umlaut over (u)}nchen, DE (2001)
- München, DE (2005)
- Belmont, CA (US) (2001 - 2006)
- San Francisco, CA (US) (2011)
Company Filing History:
6 out of 1,289 
2 out of 893 
1 out of 1 Years Active: 1998-2011
Title: Birgit Millauer: Innovator in Angiogenesis and Signal Transduction
Introduction
Birgit Millauer is a prominent inventor based in San Francisco, CA, known for her significant contributions to the fields of angiogenesis and signal transduction. With a total of seven patents to her name, she has made remarkable strides in understanding and manipulating biological processes that are crucial for various medical applications.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Cell line comprising vector encoding truncated FLK-1 receptor." This invention focuses on the use of ligands for the FLK-1 receptor to modulate angiogenesis and vasculogenesis. The research demonstrates that FLK-1 tyrosine kinase receptor expression is associated with endothelial cells, identifying vascular endothelial growth factor (VEGF) as its high-affinity ligand. This work highlights the critical role of FLK-1 in the signaling system during vasculogenesis and angiogenesis. Additionally, she has developed methods for the diagnosis and treatment of MDK1 signal transduction disorders, which involve MDK1 polypeptides and their interactions with receptor tyrosine kinases.
Career Highlights
Birgit Millauer has worked with esteemed organizations such as the Max Planck Society for the Advancement of Science and Yissum Research Development Company of the Hebrew University of Jerusalem. Her innovative research has led to advancements in therapeutic strategies for diseases characterized by abnormalities in signal transduction pathways.
Collaborations
Throughout her career, Millauer has collaborated with notable scientists, including Axel Ullrich and Werner Risau. These partnerships have further enriched her research and contributed to her success as an inventor.
Conclusion
Birgit Millauer's work exemplifies the intersection of innovation and medical science. Her patents and research continue to pave the way for new treatments and understanding of complex biological processes.